For example, in hepatocellular carcinoma (HCC), FLOT-2 was found to promote metastatic progression by controlling cell cycle progression and inducing the epithelial-mesenchymal transition (EMT) via MEK/Raf/ERK signaling activity 14. This evidence concerns the gene MAP2K7 and hepatocellular carcinoma.